Randomized Trials of Proton Therapy: Why They Are at Risk, Proposed Solutions, and Implications for Evaluating Advanced Technologies to Diagnose and Treat Cancer

J Clin Oncol. 2018 Aug 20;36(24):2461-2464. doi: 10.1200/JCO.2018.77.7078. Epub 2018 Jul 9.

Authors

Justin E Bekelman¹, Andrea Denicoff¹, Jeffrey Buchsbaum¹

Affiliation

¹ Justin E. Bekelman, University of Pennsylvania, Philadelphia, PA; Andrea Denicoff, National Cancer Institute, Bethesda, MD; and Jeffrey Buchsbaum, National Cancer Institute, Bethesda, MD.

No abstract available

Publication types

Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Humans
Neoplasms / diagnosis
Neoplasms / radiotherapy*
Proton Therapy*
Randomized Controlled Trials as Topic*
Risk Factors

Grants and funding

K07 CA163616/CA/NCI NIH HHS/United States